Cargando…

Circulating PD-L1 levels change during bevacizumab-based treatment in recurrent glioma

PURPOSE: In primary brain tumors, the efficacy of immune-modulating therapies is still under investigation as inflammatory responses are restricted by tight immunoregulatory mechanisms in the central nervous system. Here, we measured soluble PD-L1 (sPD-L1) in the plasma of patients with recurrent gl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mair, Maximilian J., Ilhan-Mutlu, Ayseguel, Pajenda, Sahra, Kiesel, Barbara, Wöhrer, Adelheid, Widhalm, Georg, Dieckmann, Karin, Marosi, Christine, Wagner, Ludwig, Preusser, Matthias, Berghoff, Anna S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571215/ https://www.ncbi.nlm.nih.gov/pubmed/33956203 http://dx.doi.org/10.1007/s00262-021-02951-2

Ejemplares similares

Soluble PD-L1 is associated with local and systemic inflammation markers in primary and secondary brain tumours
por: Mair, Maximilian J, et al.
Publicado: (2020)

LAG-3 expression in the inflammatory microenvironment of glioma
por: Mair, Maximilian J., et al.
Publicado: (2021)

Clinical Neuropathology practice news 1-2014: Pyrosequencing meets clinical and analytical performance criteria for routine testing of MGMT promoter methylation status in glioblastoma
por: Preusser, Matthias, et al.
Publicado: (2014)

Clinical characteristics and prognostic factors of adult patients with pilocytic astrocytoma
por: Mair, Maximilian J., et al.
Publicado: (2020)

Preoperative Diffusion-Weighted Imaging of Single Brain Metastases Correlates with Patient Survival Times
por: Berghoff, Anna Sophie, et al.
Publicado: (2013)

NephroCheck data compared to serum creatinine in various clinical settings
por: Pajenda, Sahra, et al.
Publicado: (2015)

Local image variance of 7 Tesla SWI is a new technique for preoperative characterization of diffusely infiltrating gliomas: correlation with tumour grade and IDH1 mutational status
por: Grabner, Günther, et al.
Publicado: (2016)

Clinical Neuropathology practice guide 5-2015: MGMT methylation pyrosequencing in glioblastoma: unresolved issues and open questions
por: Bienkowski, Michal, et al.
Publicado: (2015)

5-Aminolevulinic Acid Induced Fluorescence Is a Powerful Intraoperative Marker for Precise Histopathological Grading of Gliomas with Non-Significant Contrast-Enhancement
por: Widhalm, Georg, et al.
Publicado: (2013)

Prognostic factors in adult brainstem glioma: a tertiary care center analysis and review of the literature
por: Leibetseder, Annette, et al.
Publicado: (2021)

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors
por: Berghoff, A S, et al.
Publicado: (2012)

Enhanced expression of autophagy‐related p62 without increased deposits of neurodegeneration‐associated proteins in glioblastoma and surrounding tissue – An autopsy‐based study
por: Klotz, Sigrid, et al.
Publicado: (2022)

Noninvasive Differentiation of Meningiomas and Dural Metastases Using Intratumoral Vascularity Obtained by Arterial Spin Labeling
por: Furtner, Julia, et al.
Publicado: (2019)

Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases
por: Starzer, Angelika M., et al.
Publicado: (2021)

Response to imatinib as a function of target kinase expression in recurrent glioblastoma
por: Hassler, Marco Ronald, et al.
Publicado: (2014)

High-resolution metabolic imaging of high-grade gliomas using 7T-CRT-FID-MRSI
por: Hangel, Gilbert, et al.
Publicado: (2020)

Mapping high-grade glioma immune infiltration to 5-ALA fluorescence levels: TCGA data computation, classical histology, and digital image analysis
por: Lang, Alexandra, et al.
Publicado: (2023)

Urinary neprilysin in the critically ill patient
por: Pajenda, Sahra, et al.
Publicado: (2017)

SURG-13. EVALUATION OF 5-ALA FLUORESCENCE IN BRAIN METASTASES OF VARIOUS PRIMARY TUMORS: A MULTICENTER STUDY WITH EXPERIENCE IN 157 CASES
por: Mercea, Petra Andreea, et al.
Publicado: (2019)

BIMG-04. MAPPING HETEROGENEITY OF HIGH-GRADE GLIOMA METABOLISM USING HIGH RESOLUTION 7T MRSI
por: Hangel, Gilbert, et al.
Publicado: (2021)

Primary tumor side is associated with prognosis of colorectal cancer patients with brain metastases
por: Bergen, E.S., et al.
Publicado: (2021)

Clinical characteristics, treatment, and long-term outcome of patients with brain metastases from thyroid cancer
por: Wolff, Ladislaia, et al.
Publicado: (2023)

Clinical Neuropathology practice news 2-2014: ATRX, a new candidate biomarker in gliomas
por: Haberler, Christine, et al.
Publicado: (2014)

PSMA Expression in 122 Treatment Naive Glioma Patients Related to Tumor Metabolism in (11)C-Methionine PET and Survival
por: Traub-Weidinger, Tatjana, et al.
Publicado: (2021)

DDRGK1 in urine indicative of tubular cell injury in intensive care patients with serious infections
por: Neziri, Dashurie, et al.
Publicado: (2016)

Evaluation of the Temporal Muscle Thickness as an Independent Prognostic Biomarker in Patients with Primary Central Nervous System Lymphoma
por: Furtner, Julia, et al.
Publicado: (2021)

High correlation of temporal muscle thickness with lumbar skeletal muscle cross-sectional area in patients with brain metastases
por: Leitner, Johannes, et al.
Publicado: (2018)

Neurological symptom burden impacts survival prognosis in patients with newly diagnosed non–small cell lung cancer brain metastases
por: Steindl, Ariane, et al.
Publicado: (2020)

Descriptive statistical analysis of a real life cohort of 2419 patients with brain metastases of solid cancers
por: Berghoff, Anna S, et al.
Publicado: (2016)

5-ALA in Suspected Low-Grade Gliomas: Current Role, Limitations, and New Approaches
por: Kiesel, Barbara, et al.
Publicado: (2021)

Prognostic Value of 5-ALA Fluorescence, Tumor Cell Infiltration and Angiogenesis in the Peritumoral Brain Tissue of Brain Metastases
por: Mercea, Petra A., et al.
Publicado: (2021)

Heme Biosynthesis Factors and 5-ALA Induced Fluorescence: Analysis of mRNA and Protein Expression in Fluorescing and Non-fluorescing Gliomas
por: Mischkulnig, Mario, et al.
Publicado: (2022)

Dynamic 2-deoxy-2[18F] fluoro-D-glucose PET/MRI in human renal allotransplant patients undergoing acute kidney injury
por: Pajenda, Sahra, et al.
Publicado: (2020)

Emerging systemic treatment options in meningioma
por: Mair, Maximilian J., et al.
Publicado: (2022)

Clinical neuropathology practice guide 1-2013: Molecular subtyping of glioblastoma: ready for clinical use?
por: Woehrer, Adelheid, et al.
Publicado: (2013)

Elevated Free Thyroxine Levels Are Associated with Poorer Overall Survival in Patients with Gastroesophageal Cancer: A Retrospective Single Center Analysis
por: Puhr, H. C., et al.
Publicado: (2019)

Molecular biology of high-grade gliomas: what should the clinician know?
por: Hofer, Silvia, et al.
Publicado: (2014)

The urine biomarker panel [IGFBP7]x[TIMP-2] (NephroCheck(®) parameter) does not correlate with IGFBP7 and TIMP-2 gene expression in urinary sediment
por: Knafl, Daniela, et al.
Publicado: (2017)

Prognostic impact of genetic alterations and methylation classes in meningioma
por: Berghoff, Anna S., et al.
Publicado: (2022)

Tumor mutational burden and immune infiltrates in renal cell carcinoma and matched brain metastases
por: Steindl, A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_aqugq2df02ktk8hv2h67eokhbu